SINCLAIR PHARMA PLC

Inactive Instrument

Sinclair Pharma PLC Share Price

Equities

GB0033856740

Pharmaceuticals

Chart Sinclair Pharma PLC

Duration

Period

Style

Latest news about Sinclair Pharma PLC

European shares bounce as trade deal hopes lift risk appetite	29/18/29	RE
Huadong Medicine : Sinclair Pharma agrees to potential offer from China's Huadong (Aug 28)	29/18/29	RE
Huadong Medicine : Sinclair Pharma says Chinese firms given more time to make takeover offer	16/18/16	RE
Huadong Medicine : Britain's Sinclair Pharma gets takeover interest from Chinese firms, shares soar	05/18/05	RE
Sinclair Pharma : first-half sales up 16 percent, sees momentum continuing	19/17/19	RE
Alliance Pharma : first-half revenue rises on strong sales abroad	13/17/13	RE
Sinclair IS Pharma : says evaluating options including sale	25/14/25	RE
Sinclair IS Pharma : full-year revenue jumps as acquisitions pay off	18/14/18	RE

Press releases Sinclair Pharma PLC

Sinclair Pharma : Interim Results 2018	27/18/27	PU
Sinclair Pharma : announces $5 million investment by EW Healthcare Partners via convertible loan	22/18/22	PU
Sinclair Pharma : and ThermiGen terminate US distribution agreement	22/18/22	PU
Sinclair Pharma : Aesthetic surgery journal confirms efficacy and consumer acceptance of absorbable suture suspension	29/18/29	PU
Sinclair Pharma : Director/PDMR Shareholding	17/18/17	PU

More press releases

News in other languages on Sinclair Pharma PLC

Sinclair IS Pharma : va quitter la cote parisienne.	27/13/27
Sinclair IS Pharma PLC : Trading update	13/12/13
Sinclair IS Pharma PLC : Invida launches announcement FR	22/11/22
SINCLAIR PHARMA ORD 1P : Accord de licence avec Teva pour episil	31/11/31
SINCLAIR PHARMA ORD 1P : Accord d’option de licence pour le delmopinol	04/11/04

Managers and Directors - Sinclair Pharma PLC

Managers	Title	Age	Since
Miguel Pardos CEO	Chief Executive Officer	-	01/22/01
Santiago Calavia PRN	Corporate Officer/Principal	-	-
Julie Moreau PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Cheng Wei Liu CHM	Chairman	50	-
Miguel Pardos CEO	Chief Executive Officer	-	01/22/01
Gen Li BRD	Director/Board Member	-	27/23/27

Company Profile

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+10.86%	14.09B
CIPLA LIMITED	+13.07%	13.64B
ZYDUS LIFESCIENCES LIMITED	+37.46%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B

Generic Pharmaceuticals

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer